Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04535752
What this trial is testing

A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)

Who this might be right for
Safety and Tolerability in Healthy Volunteers
Annexon, Inc. 48
Early research (Phase 1)Study completedNCT03802552
What this trial is testing

Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections

Who this might be right for
OsteomyelitisSeptic ArthritisPyomyositis
University of Colorado, Denver 17
Early research (Phase 1)Study completedNCT01512849
What this trial is testing

Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 24
Testing effectiveness (Phase 2)Study completedNCT00340704
What this trial is testing

PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder

Who this might be right for
Bladder, Neurogenic
Boehringer Ingelheim 143
Early research (Phase 1)Study completedNCT03334084
What this trial is testing

Compare the PK, PD and Safety and Tolerability of a SC With an IV Formulation of ARGX-113 in Healthy Male Subjects

Who this might be right for
Bioavailability Study
argenx 40
Testing effectiveness (Phase 2)Study completedNCT04483115
What this trial is testing

Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Vigonvita Life Sciences 60
Early research (Phase 1)Study completedNCT01316432
What this trial is testing

PK/PD Study of Subcutaneous Cenderitide Infusion in CHF Patients

Who this might be right for
Heart FailureADHFChronic Heart Failure+1 more
Nile Therapeutics 58
Early research (Phase 1)Study completedNCT01014416
What this trial is testing

Pharmacokinetics/Pharmacodynamics (PK/PD) Characteristics of Tolvaptan Tablet in Korean Healthy Male

Who this might be right for
Healthy
Korea Otsuka Pharmaceutical Co., Ltd. 46
Early research (Phase 1)UnknownNCT04866485
What this trial is testing

Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody

Who this might be right for
Solid Tumor
Harbour BioMed (Guangzhou) Co. Ltd. 66
Early research (Phase 1)Study completedNCT03863938
What this trial is testing

Food-Effect on PK and PD of Single Oral Dose of Tegoprazan in Healthy Male Subjects

Who this might be right for
Healthy
HK inno.N Corporation 12
Early research (Phase 1)Looking for participantsNCT07093255
What this trial is testing

Safety, PK and PD of FLQ-101 in Premature Neonates

Who this might be right for
Retinopathy of Prematurity (ROP)
FELIQS INC. 18
Testing effectiveness (Phase 2)Looking for participantsNCT07644832
What this trial is testing

An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency

Who this might be right for
Hemophilia AHemophilia BFactor VII Deficiency
Shanghai RAAS Blood Products Co., Ltd. 76
Large-scale testing (Phase 3)Study completedNCT05378672
What this trial is testing

Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D

Who this might be right for
HypoglycemiaType 1 Diabetes
Zealand Pharma 8
Testing effectiveness (Phase 2)Study completedNCT06104319
What this trial is testing

Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 61
Testing effectiveness (Phase 2)Study completedNCT05731544
What this trial is testing

Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

Who this might be right for
Type 2 Diabetes Mellitus
Biomea Fusion Inc. 443
Not applicableStudy completedNCT04285034
What this trial is testing

Cardiovascular Function and Ribavirin PK/PD in Lassa Fever in Lassa Fever

Who this might be right for
Lassa Fever
University of Oxford 158
Large-scale testing (Phase 3)Study completedNCT00488839
What this trial is testing

IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Impax Laboratories, LLC 173
Testing effectiveness (Phase 2)WithdrawnNCT04968379
What this trial is testing

Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia

Who this might be right for
Iron Deficiency, Anaemia
American Regent, Inc.
Testing effectiveness (Phase 2)Study completedNCT01899703
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus

Who this might be right for
Cholestasis, Intrahepatic
GlaxoSmithKline 22
Very early researchStudy completedNCT05552274
What this trial is testing

FTIH of ECC4703 in Healthy Volunteers

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Eccogene 75
Next Page